What is the serial number for EXSCEL EXENATIDE STUDY OF CARDIOVASCULAR EVENT LOWERING?

The USPTO serial number for EXSCEL EXENATIDE STUDY OF CARDIOVASCULAR EVENT LOWERING is 85053858.

What is the registration number for EXSCEL EXENATIDE STUDY OF CARDIOVASCULAR EVENT LOWERING?

EXSCEL EXENATIDE STUDY OF CARDIOVASCULAR EVENT LOWERING is registered under USPTO registration number 0.

EXS

USPTO Trademark Record

ABANDONED

EXSCEL EXENATIDE STUDY OF CARDIOVASCULAR EVENT LOWERING

Q: Who owns the EXSCEL EXENATIDE STUDY OF CARDIOVASCULAR EVENT LOWERING trademark?

The EXSCEL EXENATIDE STUDY OF CARDIOVASCULAR EVENT LOWERING trademark is owned by Amylin Pharmaceuticals, Inc..

Q: What class is the EXSCEL EXENATIDE STUDY OF CARDIOVASCULAR EVENT LOWERING trademark registered in?

The EXSCEL EXENATIDE STUDY OF CARDIOVASCULAR EVENT LOWERING trademark is registered in Class 042 (Scientific, technology & SaaS services).

SN 85053858·Reg 0·Filed Jun 03, 2010

Owner Amylin Pharmaceuticals, Inc.

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

EXSCEL EXENATIDE STUDY OF CARDIOVASCULAR EVENT LOWERING (Serial No. 85053858), Registration No. 0, is a abandoned US trademark filed on Jun 03, 2010 by Amylin Pharmaceuticals, Inc.. This trademark covers Class 042 (Scientific, technology & SaaS services).

Mark Intelligence

EXSCEL EXENATIDE STUDY OF CARDIOVASCULAR EVENT LOWERING (Reg. #0) is an abandoned US trademark that was filed in 2010 but has since been abandoned. The mark covers Class 042 (Scientific, technology & SaaS services). Goods and services include Scientific and technological services and research and design relating thereto; industrial analysis, industrial research.... The mark faced 1 opposition proceeding during prosecution.

FILED

Jun 03, 2010

SERIAL

85053858

REG#

Owner

Applicant

Amylin Pharmaceuticals, Inc.

Entity

Corporation

State

Address

9360 Towne Centre Drive, San Diego, CA, 92121

Country

Attorney

NameEdward D. Grieff

Law firm

EDWARD D. GRIEFF AMYLIN PHARMACEUTICALS, INC.

Docket

EXSLD01-US01

Address

9360 TOWNE CENTRE DR, SAN DIEGO, CA 92121-3057, UNITED STATES

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusABANDONED

Filing DateJun 03, 2010

Serial Number85053858

Registration No.0

Status DateDec 12, 2011

Published for OppositionMar 15, 2011

Mark TypeDesign with words

Attorney DocketEXSLD01-US01

Status DescriptionDead and abandoned with no statement of use filed

Filing Signals

FILED

2010

YEARS AGO

16y

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 042Scientific, technology & SaaS services

US codes: 100, 101

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

18 events

ABANDONMENT - NO USE STATEMENT FILED

Dec 12, 2011

ABANDONMENT - NO USE STATEMENT FILED

ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED

Dec 12, 2011

ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

May 10, 2011

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Mar 15, 2011

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Mar 15, 2011

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

LAW OFFICE PUBLICATION REVIEW COMPLETED

Feb 04, 2011

LAW OFFICE PUBLICATION REVIEW COMPLETED

ASSIGNED TO LIE

Feb 01, 2011

ASSIGNED TO LIE

APPROVED FOR PUB - PRINCIPAL REGISTER

Jan 03, 2011

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Dec 02, 2010

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Dec 02, 2010

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Dec 02, 2010

TEAS/EMAIL CORRESPONDENCE ENTERED

NON-FINAL ACTION WRITTEN

Sep 13, 2010

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Sep 13, 2010

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Sep 13, 2010

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Sep 08, 2010

ASSIGNED TO EXAMINER

NOTICE OF DESIGN SEARCH CODE MAILED

Jun 10, 2010

NOTICE OF DESIGN SEARCH CODE MAILED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Jun 09, 2010

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Jun 07, 2010

NEW APPLICATION ENTERED

EXSCEL EXENATIDE STUDY OF CARDIOVASCULAR EVENT LOWERING

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by Amylin Pharmaceuticals, Inc.

Other Marks in Class 042 — Scientific, technology & SaaS services

Other Marks by Edward D. Grieff

Resources

Company